Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Kornrumpf

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nucleic Acids Research|May 16, 2025
Onkopus: precise interpretation and prioritization of sequence variants for biomedical research and precision medicineNadine S Kurz, Kevin Kornrumpf, Tim Tucholski, et al.
Nucleic Acids Research|May 27, 2024
SeqCAT: Sequence Conversion and Analysis ToolboxKevin Kornrumpf, Nadine S Kurz, Klara Drofenik, et al.
Studies in Health Technology and Informatics|September 21, 2021
Predicting the Effect of Variants of Unknown Significance in Molecular Tumor Boards with the VUS-Predict PipelineVanessa Schlotzig, Kevin Kornrumpf, Alexander König, et al.
Plos One|April 18, 2022
Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptakeThomas W Georgi, Axel Zieschank, Kevin Kornrumpf, et al.
Blood Advances|August 4, 2025
Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomasNicole Schmidt, Kevin Kornrumpf, Lena Ries, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|May 16, 2025
Onkopus: precise interpretation and prioritization of sequence variants for biomedical research and precision medicineNadine S Kurz, Kevin Kornrumpf, Tim Tucholski, et al.
Nucleic Acids Research|May 27, 2024
SeqCAT: Sequence Conversion and Analysis ToolboxKevin Kornrumpf, Nadine S Kurz, Klara Drofenik, et al.
Studies in Health Technology and Informatics|September 21, 2021
Predicting the Effect of Variants of Unknown Significance in Molecular Tumor Boards with the VUS-Predict PipelineVanessa Schlotzig, Kevin Kornrumpf, Alexander König, et al.
Plos One|April 18, 2022
Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptakeThomas W Georgi, Axel Zieschank, Kevin Kornrumpf, et al.
Blood Advances|August 4, 2025
Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomasNicole Schmidt, Kevin Kornrumpf, Lena Ries, et al.
Pageof 1